Scott Hallgren
Gastroenterology · Louisville, CONPI 1205929841
Payments from drug & device makers
Across 389 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$567
- Takeda Pharmaceuticals U.S.A., Inc.$386
- Gilead$300
- Johnson & Johnson$263
- Pfizer$214
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,705100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 189 | $2,329 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 43 | $567 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $386 |
| Gilead | 17 | $300 |
| Johnson & Johnson | 12 | $263 |
| Pfizer | 12 | $214 |
| Merck | 13 | $189 |
| Bristol Myers Squibb | 11 | $156 |
| Braintree Laboratories, Inc. | 7 | $127 |
| Regeneron Healthcare Solutions, Inc. | 6 | $120 |
| Olympus America Inc. | 6 | $112 |
| Redhill Biopharma Inc. | 6 | $103 |
| Sanofi | 5 | $101 |
| Ardelyx, Inc. | 4 | $90 |
| Lilly USA, LLC | 4 | $87 |
| QOL Medical, LLC | 6 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $69 |
| Intercept Pharmaceuticals, Inc. | 3 | $51 |
| Capsovision, Inc. | 1 | $51 |
| Medtronic | 1 | $49 |
| Echosens North America, Inc. | 1 | $40 |
| Nestle Healthcare Nutrition Inc. | 3 | $40 |
| Fresenius Kabi USA, LLC | 2 | $33 |
| Alfasigma USA, Inc. | 2 | $32 |
| Boehringer Ingelheim | 1 | $29 |
| Conmed Corporation | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Mirum Pharmaceuticals, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Organon | 1 | $8 |
How this compares
$5,705 in reported general payments places this provider in the 65th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 11 | $18,383 |
| LinzessLinaclotide | 17 | $15,116 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 176 | $11,810 |
| Pantoprazole Sodium | 388 | $5,208 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 17 | $2,796 |
| Colestipol Hcl | 20 | $2,224 |
| Omeprazole | 107 | $2,222 |
| Budesonide DrBudesonide | 24 | $2,104 |
| CholestyramineCholestyramine (With Sugar) | 17 | $1,957 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 16 | $1,917 |
| Sucralfate | 28 | $1,428 |
| Famotidine | 63 | $949 |
| Esomeprazole Magnesium | 27 | $858 |
| Metronidazole | 18 | $274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,329 | $33,49928 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $127 | $4,71333 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 304 gastroenterology providers in Colorado.
Other gastroenterology in Louisville
- Bhaktasharan PatelColorado Springs$22M
- Marcelo KugelmasEnglewood$2.7M
- Douglas AdlerColorado Springs$1.2M
- Masi KhajaGrand Junction$1.2M
- Peter McNallyFt Carson$1.1M
- Mark GerichAurora$1M
- Raj ShahAurora$764K
- Rajesh JainLakewood$708K
- Steven EdmundowiczAurora$603K
- John GoffLakewood$537K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.